In some cancer entities, immunohistochemical studies showed a correlation between TRAIL-R4, disease progression and poor patients’ prognosis, suggesting a tumor-promoting role of high TRAIL-R4 levels (Koksal et al., 2008; Ganten et al., 2009; Sanlioglu et al., 2009). This evidence concerns the gene TNFRSF10D and neoplasm.